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Background: Adolescence is a developmental stage vulnerable to alcohol drinking-related problems and the
onset of alcoholism. Hypothalamus is a key brain region for food and water intake regulation, and is one of the
alcohol-sensitive brain regions. However, it is not known what would be the alcohol effect on hypothalamus
following adolescent alcohol intake, chronically over the adolescent development, at moderate levels.
Results: We employed a paradigm of chronic moderate alcohol intake from adolescence-to-adulthood in mice,
and analyzed the alcohol effect on both behavioral and hypothalamic gene expression changes. A total of 751
genes were found and subjected to pathway analysis. The dilated cardiomyopathy (DCM) pathway was identified.
The changes of ten genes under this pathway were further verified using RT-PCR. Chronic alcohol consumption
during adolescence, even at moderate levels, led to a decrease of motor activity in mice, and also a concerted
down regulation of signaling pathway initiating factor (SPIF) genes in the DCM signaling pathway, including
β1-adrenergic receptor (Adrb1), Gs protein (Gnas), adenylyl cyclase 1 (Adcy1), and dihydropyridine receptor/L-type
calcium channel (Cacna1d).
Conclusions: These findings suggest that adolescent alcohol intake may trigger gene expression changes in the CNS
that parallel those found in the dilated cardiomyopathy signaling pathway. If such effects also take place in humans,
our findings would serve as a warning against alcohol intake in youth, such as by teens and/or college students.
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Adolescence is a critical transitional stage during which
youth mature into adulthood. This developmental stage
is characterized by a continued brain remodeling, a
process that is sensitive to the disrupting effects of alcohol
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reproduction in any medium, provided the ora developmental stage particularly vulnerable to alco-
hol drinking-related problems and the onset of alco-
holism [3-7].
The brain is one of the major target organs of alcohol.
Excessive alcohol exposure can lead to structural and
functional changes of the brain [8-11], resulting in mal-
functioning of the CNS activity, as well as deleterious in-
fluence of bodily function [12-14].
Hypothalamus is one of the alcohol-sensitive brain re-
gions [15]. Being a key brain region for food and water
intake regulation [16-18] and part of the reward system
[19-21], the hypothalamus can modulate alcohol consump-
tion and is involved in the development of alcoholism. It
has been shown that stimulation of lateral hypothalamic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Chronic self-administration of alcohol in mice during
adolescence. (A) Adolescent mice (3 weeks old) had free access to
water and alcohol solutions. Two alcohol groups were used; one group
had 5% alcohol (filled triangles), and the other had 10% alcohol (open
triangles). Data are shown for daily alcohol consumption (grams of
alcohol per kilogram mouse body weight per day, average over 5 days).
Data are expressed as mean ± S.E.M. (n = 18 for each group). There was
no statistically significant difference between the two groups at any time
point (p > 0.05, two-way ANOVA with Bonferroni post-test). (B) Alcohol
preference over water (% v/v), from the same mouse alcohol groups as
in (A), showing that mice from the 5% alcohol group consumed higher
volume of alcohol solution than those from the 10% alcohol group. The
average amounts of alcohol consumed by the 5% vs. 10% groups were
not significantly different. (C) Alcohol consumption data of the mice
used for microarray gene expression study. Mice used for the gene
expression study were selected from the 5% (n = 9) and 10% (n = 10)
alcohol group, respectively. Data are expressed as mean ± S.E.M. (n = 19).
A steady increase of alcohol consumption was present, as the alcohol
consumption data from later time points (day 40 and later) are
significantly different from the data at the beginning (p < 0.05, Repeated
measures ANOVA with post test of Dunnett's multiple comparison test).
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peptides that are found in the hypothalamus could stimu-
late alcohol intake [24-26].
Conversely, alcohol can also affect hypothalamic activ-
ities. Alcohol is known to activate the HPA axis [27-29].
It is likely that by modifying the activity of the HPA axis,
alcohol will influence, and possibly compromise, the
ability of the body to maintain or restore homeostasis and
to coordinate appropriate behavioral responses in re-
sponse to stressors [30]. In alcohol-dependent subjects,
dopamine D3 receptor (DRD3) binding in the hypothal-
amus was increased [31]. Alcohol alters genes expression
of LHRH secretory pathway in the hypothalamus of
prepubertal female rats, resulting in suppressed LHRH se-
cretion and delayed puberty [32,33]. The expression of
hypothalamic proopiomelanocortin (POMC) gene was re-
duced by prenatal exposure to alcohol in rats [34], and the
POMC expression reduction persisted into adulthood by
postnatal alcohol feeding in mice [35]. The expression of
Fos-related immediate early genes was altered following
chronic alcohol administration in mice and rats [15,36,37].
Aside from alcohol, other substances of abuse poten-
tial have been shown to influence gene activity in the
hypothalamus. Thus, cocaine increased POMC gene ex-
pression in rat hypothalamus [35], and escalated cocaine
intake correlated with a number of genes in the lateral
hypothalamic regions [38]. Nicotine exposure was shown
to affect brain development, corresponding to abnormal
hypothalamic gene expression of appetite regulators such
as down-regulation of NPY and POMC in the arcuate nu-
cleus of the hypothalamus [39].
Hypothalamus also plays a role in autonomic modula-
tion of cardiovascular system. Sympathetic nervous sys-
tem can also be activated by alcohol, and chronic
exposure of the heart to elevated catecholamine levels
released from sympathetic nerve terminals may result in
pathological changes of the heart [40,41].
Studies of the effect of chronic alcohol exposure on
the hypothalamus have been limited, particularly at the
level of gene expression changes. Specifically, it is not
known what would be the alcohol effect on hypothal-
amus following adolescent alcohol intake, chronically
over the adolescent development, at moderate levels. In
the present study, we employed a paradigm of chronic
moderate alcohol intake from adolescence-to-adulthood
in mice [42], and report here the alcohol effect on both
behavioral and hypothalamic gene expression changes.
Results
Chronic alcohol consumption
We used a two-bottle free-choice paradigm to measure
alcohol drinking [42], and studied effect of chronic alco-
hol consumption during adolescent development. Male
adolescent mice (3 weeks of age) were divided into two
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the other to 10% alcohol, so as to determine if there was
a difference in alcohol consumption behavior due to dif-
ference in alcohol concentration. In addition, a water-
only control group (each mouse had 2 bottles, both filled
with water) was used. Figure 1A showed the results of
daily alcohol consumption (grams of alcohol per kilo-
gram mouse body weight per day, average over 5 days)
for the 5% alcohol group (n = 18) and the 10% alcohol
group (n = 18). Both groups of mice consumed similar
amounts of alcohol, and there was no statistically signifi-
cant difference (F(1,306) = 0.1292, p = 0.7215, two-way
ANOVA with Bonferroni post-test). Figure 1B plotted al-
cohol preference (alcohol volume over water) from the
same mouse alcohol groups, showing that mice from the
5% alcohol group consumed higher volume of alcohol
solution than those from the 10% alcohol group. Since
the 10% alcohol solution contained higher amount of al-
cohol per unit volume than the 5% alcohol solution, we
calculated the absolute amounts of alcohol consumption
by mice from both the 5% alcohol group and the 10% al-
cohol group, and found that there was no significant dif-
ference for the absolute amount of alcohol consumed
between the 5% vs. 10% alcohol groups.
Because there was no significant difference for the
daily alcohol consumption between the 5% and the 10%
alcohol groups, we combined mice from the 5% and 10%Figure 2 Chronic alcohol consumption leads to a decrease of motor a
(C and D): rearing. Time course of locomotion (A) and rearing (C) are show
(D) for the entire period (0–60 min) are shown. Data are expressed as mea
group). *, significant difference compared with the water-only control groualcohol groups, to analyze the overall pattern of alcohol
consumption (Figure 1C). Over the course of adolescent
alcohol exposure, a trend of increased alcohol consump-
tion was observed, with alcohol consumption data from
later time points (day 40 and later) significantly different
from those in the earlier time points (p < 0.05, repeated
measures ANOVA with post test of Dunnett's multiple
comparison test). Average daily alcohol consumption
over the duration of the entire procedure (50 days) was
2.8 g/kg/day, and for the last 5 days (day 50 – 55) it was
4.3 g/kg/day. These amounts of daily alcohol consump-
tion represent a moderate level of alcohol consumption
(see Discussion).
Evaluation of motor activities indicated that chronic al-
cohol mice displayed accelerated acclimation for motor
activities (Figure 2). This is consistent with reported alco-
hol exposure-induced locomotor activity changes [43-45].
Gene expression changes after chronic alcohol exposure
For brain tissue processing for gene expression analysis,
19 mice with 7 weeks alcohol exposure were selected and
grouped into alcohol sample groups (n = 1–3 per sample
group). Samples A1-A3 had mice with relatively less
alcohol consumed (0.50 ± 0.38 g/kg/day); samples A4-A9
had mice with relatively more alcohol consumed (4.80 ±
0.36 g/kg/day); these were significantly different (p < 0.05,
Unpaired t test with Welch's correction). The rationale forctivity in mice. Upper panels (A and B): locomotion; lower panels
n as beam breaks per 5 min. Cumulative locomotion (B) and rearing
n ± S.E.M. (n = 19 for the alcohol group, n = 8 for the water-only control
p (p < 0.05, unpaired t-test).
Zou et al. BMC Neuroscience 2014, 15:61 Page 4 of 12
http://www.biomedcentral.com/1471-2202/15/61such an approach of sample pooling was to cover the
spectrum of mouse alcohol consumption behavior, so that
the underlying gene expression patterns may be discern-
ible. For water-only controls, nine mice were selected ran-
domly, and grouped into water sample groups (n = 3 per
sample group), designated samples C1-C3.
RNA samples extracted from hypothalamus were used
in gene expression analysis, using the Agilent mouse
whole genome microarray chip set. Data from all probe
sets (after passing through the filters for high-quality array
data, see Methods) were used in principal component ana-
lysis (PCA). Results of PCA were shown in Figure 3,
showing different distribution patterns of alcohol mice vs.
water mice. For component A from PCA, both water con-
trols and chronic alcohol mice showed results centered
around the 0 axis. However, while the component A re-
sults from water samples were tightly grouped around the
0 axis, that from chronic alcohol mice were spread more
widely, indicating more heterogeneity in gene expression
represented in component A. For component B, results
from water controls were tightly grouped above positive
50 level, while most (except sample A1) alcohol samples
were near (sample A6) or in the negative value range. The
distribution pattern highlighted the fact that chronic alco-
hol consumption mice had very different gene expression
patterns compared to the water controls, indicating that
chronic alcohol exposure during adolescent development
lead to altered gene expression in the hypothalamus.
Significant differences in gene expression were observed
between chronic alcohol exposure and water controls,
with 1900 regulated probes representing 1819 genes (890
up-regulated and 929 down-regulated, chronic alcohol
relative to water controls) using the t-test at the p < 0.05Figure 3 Principal component analysis (PCA) plot of microarray
gene expression study. Twelve samples were used: C1 – C3 for
water control mice (open circles), and A1 – A9 for alcohol
consumption mice (filled squares). All probe sets that passed the
filters for high-quality array data (see Methods) were used for the
analysis. Component A is plotted on the horizontal axis and
component B is plotted on the vertical axis.(Additional file 1: Table S1 and Additional file 2: Figure
S1). Unsupervised hierarchical clustering analysis based
on these differentially expressed genes also showed dis-
tinct clustering of the alcohol hypothalamus samples
compared with control hypothalamus samples (Figure 4
and Additional file 2: Figure S1).Pathway analysis of differentially expressed genes
Of the 1819 differentially expressed genes, 340 genes
showed less than 0.83 fold change (representing 20%
down-regulation of chronic alcohol exposure relative to
water control) and 411 genes showed more than 1.2 fold
change (representing 20% up-regulation of chronic alcohol
exposure relative to water control). These 751 genes were
chosen for pathway analysis, and several pathways were
identified (Additional file 3: Table S4). One pathway
showed p < 0.01 — the dilated cardiomyopathy pathway,
from the pathway enrichment analysis by both DAVID
Functional Classification Analysis and Web-based Gene
Set Analysis, and was chosen for further studies.Figure 4 Clustering display of differentially expressed genes
using the unsupervised hierarchical clustering method. C1-C3
represent water-only control samples; A1-A9 are for chronic
alcohol samples.
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To provide independent validation of the identified gene
pathway from microarray analysis of gene expression
data, real-time PCR was used to measure gene expres-
sion level changes with the same RNA samples used in
the microarray experiment. We studied ten genes in the
dilated cardiomyopathy (DCM) pathway that were iden-
tified as differentially expressed genes (p < 0.05, showing
20% up- or down-regulation), as well as two other genes
in the DCM pathway with “borderline” difference (Adrb1,
p < 0.06, 0.78-fold change; Prkx, p < 0.03, 0.94-fold change)
because of their key positions in the DCM pathway; in
addition, Jup was tested, as an internal control, because it
was among those identified by microarray analysis, but was
not situated in the β1AR-DHPR-Ca2+ branch of the DCM
pathway. Seven candidate genes among the thirteen tested
were validated by real-time PCR as differentially expressed
genes, giving a 53.8% positive confirmation rate. Table 1
lists the seven genes that showed significantly differentiated
expression between the chronic alcohol samples and the
water control samples: Adrb1, Gnas, Adcy1, Cacna1d, and
Itga4 with down-regulation, while Des and Igf1 with up-
regulation. Interestingly, the four genes with the strongest
statistical difference (Adrb1, Gnas, Adcy1, and Cacna1d)
all showed down-regulation, and they all code for proteins
which initiate the signaling steps in the β1AR-DHPR-Ca2+
branch of the DCM pathway (see diagram in Figure 5),
suggesting that this branch may be impacted by chronic al-
cohol consumption during adolescence.
Discussion
In this study, we used mice to study chronic alcohol
consumption during adolescence and its effect on geneTable 1 RT-PCR confirmation of differential gene expression i
Gene symbol Gene name Microarray p-v
Cacna1d Calcium channel, voltage-dependent,
L type, alpha 1D subunit
0.005*
Gnas GNAS (guanine nucleotide binding protein,
alpha stimulating) complex locus
0.006*
Adrb1 Adrenergic receptor, beta 1 0.062
Adcy1 Adenylate cyclase 1 0.030*
Itga4 Integrin alpha 4 0.011*
Adcy3 Adenylate cyclase 3 0.024*
Prkx Protein kinase, X-linked 0.033*
Cacnb4 Calcium channel, voltage-dependent,
beta 4 subunit
0.017*
Igf1 Insulin-like growth factor 0.012*
Des Desmin 0.004*
Sgcd Sarcoglycan, delta (dystrophin-associated
glycoprotein)
0.013*
Tnni3 Troponin I, cardiac 3 0.041*
*p < 0.05.expression and behavior in adulthood. We selected ICR
mice for this study, instead of the more commonly used
C57BL6 mice, for two reasons: (1) ICR mouse is an out-
bred mouse strain with inter-individual variability — simi-
lar to the outbred nature of humans. Using an outbred
mouse strain such as ICR to study alcohol effect would
more closely model the effect of alcohol in humans. (2) As
an inbred strain, C57BL6 mice are known to drink consid-
erably more alcohol than other mouse strains [46]. Thus,
C57BL6 mice may represent only a special case regarding
alcohol drinking behavior. Outbred mice such as ICR have
been shown to consume less alcohol and exhibit lower
preference for alcohol than C57BL6 mice [47]; in a prefer-
ence test with 3% – 30% alcohol, the mean maximally pre-
ferred concentrations of alcohol were approximately 18%
for C57BL6 mice vs. 7% for ICR mice [48]. We chose a
two-bottle free-choice paradigm to measure alcohol drink-
ing, as animals have unrestricted access to both water and
alcohol for their own choice, thus better modeling the
free-choice nature of human access to alcohol; such an ap-
proach has been used to identify the genetic basis for alco-
hol preference and dependence [49-56].
In our study, mice started chronic alcohol drinking
from the age of about 4 weeks old and lasted seven
weeks, covering the entire period of adolescence-to-
adulthood development in mice. During this time, a
trend of increased alcohol consumption was observed
(Figure 1C), with an overall average alcohol consump-
tion of 2.8 g/kg/day. This represents a moderate level of
alcohol consumption, as it is comparable to the lower
range of alcohol intake in a cross-mouse strain study of
alcohol intake during the 4-hour daily drinking session
using the drinking-in-the-dark model [46]. Using FDA’sn hypothalamus between alcohol and water groups













Figure 5 Hypothesis of adolescent chronic alcohol consumption effect on SPIF gene down regulation in the dilated cardiomyopathy
signaling pathway. Diagram was adapted from KEGG pathway (http://www.genome.jp/kegg/) [92] for dilated cardiomyopathy (DCM), showing
the β1AR-DHPR-Ca2+ branch of the DCM pathway. Adolescent chronic alcohol consumption is hypothesized to result in the down regulation of
SPIF genes (marked with grey color and solid down arrows), including β1-adrenergic receptor (Adrb1), Gs protein (Gnas), adenylyl cyclase 1
(Adcy1), and dihydropyridine receptor/L-type calcium channel (Cacna1d). The coordinated down regulation of these SPIF genes leads to impaired
intracellular Ca2+ homeostasis at the cellular level.
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equivalent doses (HED) based on body surface area [57],
this level of alcohol consumption in mouse is roughly
equivalent to about 1–2 glasses of wine in a 60 kg adult
human. Interestingly, such a relatively moderate level of
alcohol drinking during adolescent development still
resulted in a pattern of gene expression change in hypo-
thalamus; in particular, for certain genes that have been
shown to be involved in the dilated cardiomyopathy
(Figure 5).
Adolescent chronic alcohol intake in mice results in a
pattern of gene regulation in the hypothalamus
Our results showed that chronic alcohol intake influences
hypothalamic gene expression. From our microarray ana-
lysis of hypothalamic gene expression, 1,819 genes showed
significant changes, of which 751 displaying gene expres-
sion change of 1.2 fold or higher. PCA (Figure 3) and clus-
tering analysis (Figure 4) showed that, compared with
water controls, alcohol intake in mice displayed a pattern
of hypothalamic gene expression changes. Using pathway
analysis of the differentially expressed genes, we found
that dilated cardiomyopathy (DCM) pathway is one of the
major pathways that was affected by chronic alcohol in-
take. Using RT-PCR, five genes in the DCM pathway
(Adrb1, Gnas, Adcy1, Cacna1d, and Itga4) are down-
regulated in chronic alcohol mice relative to water con-
trols, and two genes were up-regulated (Des and Igf1)(Table 1). Of the five down-regulated genes, four of them
(Adrb1: β-1 adrenergic receptor, β1AR; Gnas: guanine nu-
cleotide binding protein, alpha stimulating, Gsα; Adcy1:
adenylyl cyclase 1, AC1; and Cacna1d: calcium channel,
voltage-dependent, L type, alpha 1D subunit, D-LTCCs)
belong to the β1AR-DHPR-Ca2+ branch of the DCM
pathway (Figure 5). The functions of these gene products
are closely related: β-adrenergic receptors are coupled to
G proteins including Gnas, which stimulates adenylyl cy-
clase, and results in increased cAMP levels. The primary
target for cAMP is protein kinase A, which phosphory-
lates several proteins including Cacna1d, which regulates
Ca2+ influx into the cytosol from intracellular Ca2+
stores endoplasmic reticulum in neurons and sarcoplas-
mic reticulum in cardiac myocytes. What these genes
share in common is that they all code for proteins which
initiate the signaling steps of this pathway. Thus, we
term these gene products “signaling pathway initiating
factors” (SPIFs).
Our results corroborate with evidence from human
and rodent studies where chronic alcohol treatment was
used. In human, chronic alcoholism was shown to be re-
lated to the reduced Gsα levels in the temporal cortices of
postmortem brains [58]. Also, postmortem brains of alco-
holics showed a significant reduction of adenylyl cyclase 1
in both frontal and temporal cortices [59]. In addition,
adenylyl cyclase mRNA levels in the blood were signifi-
cantly lower in alcoholics than in controls [59]. Cyclic
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holics [60]. Some of these molecular effects appear long-
lasting. For example, in platelet membranes, adenylyl
cyclase activity was lower in alcoholics who had abstained
from alcohol for one to four years [61].
In rodents treated with chronic alcohol, it has been
shown that in myocardial membranes, β-adrenergic re-
ceptor and cAMP levels were decreased [62], similar to
our observations at the mRNA levels of these proteins
(Table 1). In addition, β-adrenergic receptor density in
the heart was decreased by alcohol exposure [63]. There
are also ample evidence of chronic alcohol-related re-
duction in rodents for adenylyl cyclase and G proteins in
the CNS, including cerebral cortex [64,65], pituitary
[66], and cerebellum and pons [67]. These reports dem-
onstrate that chronic alcohol treatment in vivo show a
consistent pattern of reduction in β-1 adrenergic recep-
tor, G protein, and adenylyl cyclase, consistent with our
observations for the SPIFs, and suggesting that alcohol-
induced impairment of these SPIFs may represent a ra-
ther common pathophysiological outcome from chronic
alcohol exposure.
Of the down-regulated SPIF genes in the DCM path-
way, the activity and function of Cacna1d in the hypo-
thalamus was not well-understood. Cacna1d encodes the
voltage-gated L-type Ca2+ channel formed by a1D sub-
units. Ca2+ channel involvement in cardiovascular func-
tion is known. For example, mice deficient of the alpha-
1D subunit of the Ca2+ channel showed bradycardia and
arrhythmia as a result of the sinoatrial node dysfunction
[68-70]. D-LTCC channels are present in the atrial tis-
sues of the heart where it contributes to pace-making
[68]. D-LTCC channel opening results in Ca2+ influx,
which activities ryanodine receptor, thus mediating Ca2+
release from intracellular Ca2+ stores such as sarcoplas-
mic reticulum [71], leading to cardiac muscle contrac-
tion. In the brain, D-LTCC channels are important in
regulating neuronal activity [72,73]. In hippocampus, for
example, these channels are involved in both long-term
potentiation and long-term depression by coupling with
ryanodine receptors [74]. These Ca2+ channel functions
in the hypothalamus are little understood, however.
Potential relationship between the hypothalamic gene
regulation pattern and alcohol-induced cardiovascular
disease
Regarding hypothalamic gene expression influenced by
alcohol, there lacks reported studies about the four SPIF
genes we studied. Based on the above-cited evidence of
hypothalamus involvement in cardiovascular function,
and of the hypothesized involvement of some of these
genes in cardiovascular diseases, it is possible that the
alcohol-mediated gene down-regulation in the hypothal-
amus that we observed is related to alcohol-inducedcardiovascular disease. Our hypothesis is based on the fol-
lowing considerations:
1. Hypothalamus is a key CNS site for cardiovascular
regulation. Hypothalamus is involved in many
functions of the sympathetic nervous system, which
tightly regulates cardiovascular activity [75-78].
Therefore, changes in hypothalamic gene expression
are likely to influence the cardiovascular system,
including cardiac muscles. Our study documented
hypothalamic gene expression changes in the DCM
pathway brought on by chronic alcohol
consumption. Given the key role that hypothalamus
plays in sympathetic regulation of cardiovascular
function, the concerted gene down regulation
pattern that we observed in hypothalamus is likely
to be involved in regulating cardiovascular function.
2. Chronic alcohol intake can lead to cardiac muscle
damage in human and animals, resulting in
alcohol-induced cardiac muscle diseases, even heart
failure. In dilated cardiomyopathy and heart failure
patients, sympathetic system activation and cardiac
β-1 adrenergic receptor down regulation are
important characteristics of end-stage dilated
cardiomyopathy and heart failure [79-81]. Alcohol can
activate the sympathetic nervous system, leading to
down regulation of cardiac βAR, Gs, and AC in
human alcoholics and rats consuming chronic alcohol
[60-63]. This is consistent with our observation that
in the hypothalamus of chronic alcohol-drinking mice,
the SPIFs of the DCM pathway showed concerted
down regulation. Thus, chronic alcoholic intake leads
to the DCM pathway SPIF down regulation in both
the hypothalamus and the cardiovascular system.
These results suggest that the SPIFs of the DCM
pathway may play an important role in the
development and progression of alcohol-mediated
cardiovascular system injury and diseases (such as
alcohol induced cardiac disease and heart failure).
3. Cacna1d codes for the dihydropyridine receptor
(DHPR), which functions as a Ca2+ channel to
affect Ca2+ influx across the cell membrane. In
Cacna1d partial knockout mice, heart dysfunction
was reported [68-70]. In neurons, Ca2+ channels
mediate depolarization-induced Ca2+ influx
across the plasma membrane of excitable cells,
thus regulating the key physiological processes
[68,82]. There is no prior report of alcohol-induced
Cacna1d down regulation in the hypothalamus.
In our study, the concerted down regulation of the
SPIF genes in the hypothalamus includes Cacna1d.
It is possible that decreased synaptic transmission
and neuropeptide secretion in the hypothalamus
may influence cardiovascular functions.
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consume over 90 g of alcohol a day for over five
years are at high risk for developing asymptomatic
DCM; those who continue to drink alcohol for over
15 years may experience symptomatic DCM, leading
to potential heart failure [83,84]. It is observed that
with chronic alcohol consumption, metabolic
changes occur within a few weeks [85,86], but signs
of depressed contractile function are detectable only
after several months of alcohol consumption [87,88].
In our study, the amount of alcohol consumed by mice
is in the range of moderate levels, lasting about seven
weeks. DCM pathway gene expression is already influ-
enced in the hypothalamus under such conditions. This
indicates two issues: (a) the drinking activities spanned the
adolescence development, highlighting the danger of ado-
lescent alcohol consumption even at moderate levels, and
the potential harmful effect later in adulthood for cardio-
vascular function; and (b) gene activity changes in the
hypothalamus may precede noticeable changes in body’s
physiology and function, suggesting that these changes in
DCM pathway genes may serve as early warning signs for
alcohol’s harmful effect.
It should be pointed out that hypothalamus is a neu-
roanatomically heterogeneous brain structure, with vari-
ous nuclei subserving diverse functions. Samples in our
study encompassed much of the hypothalamus, there-
fore potentially diluting the extent of local gene expres-
sion changes. Future studies with more localized brain
tissue collection will be helpful to delineate the roles of
sub-hypothalamic regions in alcohol consumption and
gene modulation. Another point to note is that, although
the observed differences in alcohol consumption were not
statistically significant between the 5% and 10% groups of
mice, there still might be subtle differences in related gene
expression changes, but our study design did not allow for
distinguishing expression changes that are related to the
5% vs. 10% alcohol groups. Further studies with larger
group sizes would offer improved opportunities to distin-
guish gene expression differences between different alco-
hol concentration groups. Additional limitations of this
study relate to the fact that only hypothalamic tissues of
the brain were studied for gene expression changes; it
would be beneficial in future studies to examine cardiac
tissues for alcohol-affected genes observed in this study,
as a way to validate the findings of the present study. An-
other issue of note is that in our study, access to alcohol
by mice was allowed to continue throughout the study,
without any washout period. This study design was chosen
to avoid any potential complication from alcohol with-
drawal effect, both behaviorally and at the gene expres-
sion level, that would likely to occur if a no-drinking
washout period were to be instituted. Thus, because ofthe continued access to alcohol, acute alcohol actions
may contribute to the results observed in this study.
Conclusions
This study showed that chronic alcohol consumption
during adolescence, even at moderate levels, may trigger
gene expression changes in the CNS that parallel those
found in dilated cardiomyopathy (DCM). If such effects
also take place in humans, our findings would serve as a




Male ICR (Institute for Cancer Research) outbred mice
were obtained from Shanghai Laboratory Animal Center,
Chinese Academy of Sciences, Shanghai, China. ICR out-
bred mice were also known as CD-1 (Caesarean Derived-
1), and it is a commonly used outbred mouse strain.
Animals were singly-housed in temperature controlled
animal facilities on a 12 hr:12 hr light–dark cycle with
food and water available ad libitum. Recording of water/al-
cohol consumption was conducted during the light cycle,
about 4 hours after the light cycle began. Also, behavioral
tests were conducted during the light cycle, beginning
3 hours after the light cycle began, and concluding no less
than 2 hours before the end of the light cycle.
Principles of laboratory animal care were followed in ac-
cordance with the Guide for the Care and Use of Labora-
tory Animals (Institute of Laboratory Animal Resources,
1996), the PRC National Standards for Laboratory Animal
Quality, and the Guidelines for the Use of Experimental
Animals.
Chronic alcohol self-administration
For the chronic alcohol drinking experiment, the para-
digm of two-bottle choice was used [42]. Each cage was
equipped with two drinking tubes. The drinking tubes
were made from 10 ml plastic serological pipettes (Coster
Stripette), with 0.1 ml graduation. The narrow tip of the
pipette was cut off and a stainless steel sipper tube was
connected through a silicone tubing. Animal’s body weight
and the food consumption were measured on weekdays.
Before chronic alcohol drinking began, mice (3 weeks
old) were allowed to adapt to the drinking tubes with
both tubes containing water from experimental day 1–5.
After this adaptation period, mice were randomly assigned
to 5% alcohol group, 10% alcohol group, or water-only
control group (n = 16–18). For the water-only control
group, two drinking tubes in each cage contained deion-
ized water throughout the duration of the experiment. For
the alcohol groups, one drinking tube contained 5% or
10% alcohol solution while the other contained water.
The amount of the water or alcohol consumption was
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was refreshed every day, and the positions of the two
tubes in the cage were switched daily to avoid any side
bias.
Motor activities measurement
Behavior tests began on day 50 of the experiment. For
motor activity measurement, an automated beam break
detection system (San Diego Instruments) was used as
previously described [89]. Animals were placed individu-
ally in plastic chambers (48 × 24 × 20 cm, LxWxH) with
bedding material, and the chamber was covered with a
piece of glass on the top. Each chamber was placed in-
side a wooden enclosure (60 × 40 × 44 cm, LxWxH) that
was sound- and light-proof, illuminated from inside with
a fluorescence light (5 W). Motor activity was measured
via automated detection of infrared beam breaks. Rear-
ing behavior was detected by a second set of infrared
photodetectors mounted 7.7 cm above the ground.
RNA extraction and DNA microarray
Chronic alcohol drinking lasted to day 57 of the experiment
without any change and interruption. Then each mouse is
sacrificed by decapitation, and the hypothalamus was dis-
sected for rapid freeze and storage at −80°C. Hypothalamus
tissue samples were used for total RNA extraction.
Total RNA was isolated using the TRIzol reagent
(Invitrogen, Carlsbad, CA) and purified with RNeasy
column (Qiagen, Valencia, CA). RNA concentration and
purity were analyzed with Nanodrop spectrophotometer
(Nanodrop Technologies, Wilmington, DE), with the
spectral absorption at 260 and 280 nm. RNA integrity
was assessed with Bioanalyzer 2100 (Agilent Technolo-
gies, Palo Alto, CA). All RNA samples had RNA Integ-
rity Numbers (RIN) of 8.4 or higher and 28S/18S ratio
of 1.5 or higher.
RNA samples were pooled for microarray. For water-
only group, nine mice were used to make three pools,
with three equal amounts of RNA samples per pool. For
alcohol group, nineteen mice were used to make nine
pools, with one to three equal RNA samples per pool,
where samples A1-A3 had mice with relatively less alcohol
consumed and samples A4-A9 had mice with relatively
more alcohol consumed (Additional file 4: Table S3).
The microarray study was carried out as mono-color
experiment. Total RNA was Cy3 labeled according to
Agilent’s Low RNA Input Fluorescent Linear Amplifica-
tion Kit and hybridized onto Agilent Whole Mouse Gen-
ome 4 × 44 K G4122F microarrays containing 43,604
probes as described in the manufacturer's protocol. Slides
were scanned (Agilent G2505B) at 5 μm resolution using
an extended dynamic range protocol, and images were
processed with Agilent Feature Extraction software 9.5.
Within-array normalization was performed using the“Background detrending” software (Agilent). The non-
uniform outlier features (spots) were removed and the in-
tensity values were transformed to a log base 2 scale. The
microarray data have been deposited in Gene Expression
Omnibus with the accession code GSE42770.
Microarray data analysis
The spots with low signal noise ratio (<2) were automatic-
ally eliminated, and only “perfect value” of those genes
present in > 50% samples in each group were applied in
further analysis. Principal component analysis (PCA) was
used to summarize gene expression profiles between
groups. Differentially expressed genes (DEGs) were de-
termined by comparing with the control group, using a
corresponding t-test with the significance level set at
p-value < 0.05 and q-value (false discover rate) at < 0.05
[90]. Hierarchical clustering and visualization were per-
formed using Cluster 3.0 and TreeView software (M. B.
Eisen Laboratory, Stanford University, Stanford, CA).
Average linkage with the uncentered correlation similar-
ity metric was used for the clustering of samples. Path-
way analysis was carried out using DAVID Functional
Classification tool [91], the open source pathway resources
of Kyoto Encyclopedia of Genes and Genomes (KEGG)
(http://www.genome.jp/kegg/) [92], and the Web-based
Gene Set Analysis Toolkit (WebGestalt) [93].
Real-time PCR
Based on our analysis of significant biological pathways
that are associated with the identified differentially
expressed genes, real-time PCR was used to verify the
status of differential expression and to exclude false
positives. For internal control, we initially evaluated two
genes (β-actin and glyceraldehyde-3-phosphate dehydro-
genase, or Gapdh). Both β-actin and Gapdh showed stable
expression in each sample in the microarray, therefore they
both qualified as internal control at this point. From there,
we used qRT-PCR to measure both genes’ expression levels
in our samples (C1-C3, A1-A9), utilizing the NormFinder
program [94]. The NormFinder software adopts a model-
based variance estimation approach to identify genes suited
for normalization, and provides a rank order according to
gene’s expression stability. According to this program,
β-actin was identified as the more stably expressed gene,
and was therefore selected as reference gene for gene
expression normalization in the qRT-PCR experiment.
The sequences of the primers for the target genes and
the internal control gene (β-actin) are listed in Additional
file 5: Table S2.
For cDNA synthesis, oligo(dT) primers, 2 μg of each
total RNA sample used in microarray experiment, and
the Superscript II reverse transcriptase (Invitrogen) were
used, following the guidelines of the manufacturer. cDNA
samples were placed on ice and stored at −20°C until
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ple was diluted with 360 μl of MilliQ water. qPCR reac-
tions were performed with the Prism 7900 Sequence
Detection System (Applied Biosystems, Foster City, CA).
For each reaction, 1 μl of each diluted cDNA sample was
added to a mixture containing 10 μl of 2 × SYBR green II
qRT-PCR kit (Toyobo, Osaka, Japan), 1 μl of each primer
(5 μM), and 8 μl of MilliQ water. Cycling conditions were
10 min 95°C, followed by 40 cycles of 15 s at 95°C and
1 min at 60°C. After cycling, a melting protocol was per-
formed with 15 s at 95°C, 1 min at 60°C, and 15 s at 95°C,
to control for product specificity.
The fold change (FC) in target gene cDNA relative to
selected endogenous control gene was determined as
follows: FC = 2-ΔΔCt, where ΔΔCt = (CtTarget - CtControl)
test - (CtTarget - CtControl)control. Ct values were defined
as the number of the PCR cycles at which the fluores-
cence signals were detected. In qRT-PCR analysis, data
are presented as mean ± SEM and analyzed with t-test
by SPSS 13.0 (SPSS Inc, Chicago, IL).
Statistics
Repeated measures two-way ANOVA with Bonferroni
post tests was used to compare the two chronic alcohol
groups (5% and 10%) in daily alcohol consumption. Re-
peated measures ANOVA with post test of Dunnett's
multiple comparison test was used to compare daily al-
cohol consumption between the first time point and
other time points. Unpaired t-test was used to compare
the chronic alcohol and water-only control mice in loco-
motion and rearing behavior.
Additional files
Additional file 1: Table S1. List of differentially expressed genes
identified in microarray analysis between chronic alcohol consumption
and water-only control.
Additional file 2: Figure S1. Heat map of genes differentially expressed
between chronic alcohol vs. control mouse hypothalamus samples. Gene
expression values are color-coded according to the scale on the right.
Displayed on top is the clustering display of differentially expressed genes
using the unsupervised hierarchical clustering method. C1-C3: water-only
control samples; A1-A9: chronic alcohol samples.
Additional file 3: Table S4. Top 5 pathways from DAVID Functional
Classification Analysis and Web-based Gene Set Analysis.
Additional file 4: Table S3. Pooling of RNA samples from alcohol mice.
Additional file 5: Table S2. Sequences of primers for qRT-PCR.
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